Brief: Xintela's GMP Facility Approved For Manufacturing Of Cell Therapy Products
21/05/2021 07:42
May 21 (Reuters) - Xintela AB XINT.ST :
* XINTELA'S GMP FACILITY APPROVED FOR MANUFACTURING OF CELL
THERAPY PRODUCTS
* RECEIVED PERMISSION FROM MEDICAL PRODUCTS AGENCY TO
PRODUCE CELL
THERAPY PRODUCTS (ATMPS), IN ITS OWN GMP FACILITY
Source text for Eikon: ID:nBQN20t35j
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))